Inovio Pharmaceuticals, Inc. (INO) Tops Q1 Loss Views
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.10 +1.85%
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (NYSE: INO) reported Q1 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.08 million.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Argus Starts SpaceX (SPCX) at Hold
- Hyperscale Data acquires 48.5 acres to expand Michigan campus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
